Leading provider of respiratory monitoring technology, PMD Solutions saw outstanding success at this year’s MEDICA event. Showcasing its revolutionary RespiraSense™ product, the high growth early stage medical device company was invited by Enterprise Ireland to be part of the Irish pavilion where they were represented on a world stage among some of the globes leading Medtec organisations.
Minister for Trade, Employment, and Business, Pat Breen TD said “I am delighted but not surprised with PMD Solutions’ recent successes. I had the pleasure of visiting them at this year’s MEDICA event and was extremely impressed by their high levels of innovation and entrepreneurship. It is wonderful to see an Irish company at the forefront of medical technology advances. They serve as a great example to all Irish companies with ambitions to trade internationally.”
Sheila O’Loughlin, Senior Market Adviser, Enterprise Ireland states “PMD Solutions has achieved significant traction in the UK market, further strengthened by its recent acceptance on the prestigious NHS Innovation Accelerator Programme. We will continue to support them as they expand into European and global markets.”
Speaking about the company’s recent successes, Myles Murray, CEO, PMD Solutions said, “We are most grateful to Enterprise Ireland for giving us this fantastic opportunity to showcase RespiraSense to the global healthcare industry. We have created an innovation that is set to change the face of in-hospital monitoring at a global scale, improve patient outcomes and generate substantial cost savings for healthcare providers.”
Clinical evaluations of RespiraSense throughout Europe and Australia have seen significant results regarding improving patient care and long-term healthcare economic savings. The device has proven to detect patient deterioration up to 12 hours in advance of an adverse patient event, allowing for early intervention and reducing escalations of care and the associated hospital cost.